Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Front Pharmacol ; 10: 1522, 2019.
Article in English | MEDLINE | ID: mdl-31998126

ABSTRACT

Radix angelicae pubescentis (RAP) has been used in Chinese traditional medicine to treat painful diseases such as rheumatism and headache. A previous study has reported that columbianadin (CBN), a major coumarin in RAP inhibits acute and inflammatory pain behaviors. However, the effects of CBN on neuropathic pain behaviors, and the potential underlying mechanism have not been reported. In the present study, the effects of CBN, compared to another major coumarin of RAP osthole (OST), on oxaliplatin-induced neuropathic pain behaviors and on the voltage-gated calcium currents in small dorsal root ganglion (DRG) neurons were studied in mice. It was found that CBN and OST inhibited both mechanical and cold hypersensitivity induced by oxaliplatin. Moreover, CBN and OST might preferentially inhibit T- and L-type calcium currents (Ica). The inhibitory effects of CBN and OST on the oxaliplatin-induced mechanical allodynia were prevented by gabapentin. These results suggest that CBN, as well as OST might inhibit neuropathic pain behaviors through an inhibition of T- and L-type calcium currents in nociceptive DRG neurons.

2.
Neurosci Bull ; 30(1): 67-73, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24338484

ABSTRACT

Epigallocatechin-3-gallate (EGCG), a major polyphenol in green tea, has been considered a potential therapeutic and chemopreventive agent for cancer. Glioma is a malignant tumor with high mortality but effective therapy has not yet been developed. In this study, we found that EGCG induced apoptosis in U251 glioma cells via the laminin receptor (molecular weight 67 kDa) in a time- and dose-dependent manner, decreased their invasiveness and inhibited their proliferation. The mitogen-activated protein kinase pathway was shown to be involved in glioma cell apoptosis and proliferation. Furthermore, the mRNA levels of matrix metalloproteinase (MMP)-2 and MMP-9 were reduced after EGCG treatment. These results suggest that EGCG has important therapeutic effects with low toxicity and side-effects, and could be used in cancer chemoprevention.


Subject(s)
Anticarcinogenic Agents/therapeutic use , Apoptosis/drug effects , Catechin/analogs & derivatives , Glioma/drug therapy , Catechin/therapeutic use , Cell Line, Tumor , Cell Movement/drug effects , Cell Proliferation/drug effects , Glioma/metabolism , Humans , MAP Kinase Signaling System/drug effects , MAP Kinase Signaling System/physiology , Matrix Metalloproteinase 1/metabolism , Matrix Metalloproteinase 9/metabolism
3.
Sheng Li Xue Bao ; 61(2): 115-20, 2009 Apr 25.
Article in English | MEDLINE | ID: mdl-19377821

ABSTRACT

In the present study, the intracellular free calcium concentration ([Ca(2+)](i)) in acutely isolated rat dorsal root ganglia (DRG) neurons modulated by loureirin B, an active component of "dragon's blood" which is a kind of Chinese herbal medicine, was determined by the means of Fura-2 based microfluorimetry. It was found that loureirin B could evoke the elevation of [Ca(2+)](i) in a dose-dependent manner. However, the elevation of [Ca(2+)](i) evoked in the calcium free solution was much smaller than that in the standard external cell solution, suggesting that most change of [Ca(2+)](i) was generated by the influx of extracellular Ca(2+), not by the activities of intracellular organelles like Ca(2+) stores and mitochondria. In addition, the mixture of loureirin B and caffeine also induced [Ca(2+)](i) rise, but the peak of [Ca(2+)](i) rise induced by the mixture was significantly lower than that by caffeine alone, which means the triggering pathway and the targets of caffeine are probably involved in loureirin B-induced [Ca(2+)](i) rise. Moreover, compared to the transients induced by caffeine, KCl and capsaicin, the loureirin B-induced [Ca(2+)](i) rise is much slower and more stable. These results indicate that the capability of loureirin B of inducing the [Ca(2+)](i) rise is solid and unique.


Subject(s)
Calcium/metabolism , Neurons, Afferent/drug effects , Resins, Plant/pharmacology , Animals , Caffeine/pharmacology , Ganglia, Spinal/drug effects , Ganglia, Spinal/metabolism , Neurons, Afferent/metabolism , Rats
4.
J Ethnopharmacol ; 117(2): 332-8, 2008 May 08.
Article in English | MEDLINE | ID: mdl-18343613

ABSTRACT

AIM OF THE STUDY: Asian scorpion Buthus martensi Karsch (BmK) is widely used to treat neurological symptoms, especially chronic pain, in traditional Chinese medicine for thousands of years. BmK AS, a polypeptide from BmK venom, could produce peripheral potent anti-nociceptive effects in rats. In the present study, spinal anti-nociceptive effects of BmK AS were investigated in rat formalin test. MATERIALS AND METHODS: Spinal anti-nociceptive activity of BmK AS was studied using formalin test in rats. BmK AS in doses of 0.02, 0.1 and 0.5 microg was administered intrathecally before formalin injection 10 min. The suppression by intrathecal injection of BmK AS on formalin-induced spontaneous nociceptive behaviors and spinal c-Fos expression were investigated. RESULTS: Intrathecal injection of BmK AS markedly reduced formalin-evoked biphasic spontaneous nociceptive behaviors in a dose-dependent manner. Formalin-induced c-Fos expression could be dose-dependently inhibited by BmK AS in superficial (I-II), the nucleus proprius (III and IV) and deep (V-VI) dorsal horn laminae, but not in the ventral gray laminae (VII-X) of lumbar spinal cord. The suppression by BmK AS on c-Fos expression in superficial laminaes was much stronger than that in deep laminaes. CONCLUSION: The present study demonstrates that BmK AS is capable of producing remarkable anti-nociceptive effects not only in periphery but also in spinal cord.


Subject(s)
Analgesics/pharmacology , Pain Measurement/drug effects , Peptides/pharmacology , Scorpion Venoms/chemistry , Animals , Dose-Response Relationship, Drug , Formaldehyde , Gene Expression/drug effects , Genes, fos/drug effects , Immunohistochemistry , Injections, Spinal , Male , Peptides/administration & dosage , Peptides/chemistry , Rats , Rats, Sprague-Dawley , Scorpion Venoms/administration & dosage , Scorpion Venoms/pharmacology
5.
J Neurochem ; 84(2): 325-35, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12558995

ABSTRACT

Martentoxin, a novel K+-channel-specific peptide has been purified and characterized from the venom of the East-Asian scorpion (Buthus martensi Karsch). The whole cDNA precursor sequence suggested that martentoxin was composed of 37 residues with a unique sequence compared with other scorpion neurotoxins. The genomic DNA of martentoxin showed an additional intron situated unexpectedly in the 5' UTR region, besides one located close to the C-terminal of the signal peptide. The patch-clamp recording found that martentoxin at the applied dose of 100 nm could strongly block large-conductance Ca2+-activated K+ (BKCa) currents in adrenal medulla chromaffin cells, and BKCa currents blocked by martentoxin could be fully recovered within 30 seconds after washing, which is at least 10 times faster than recovery after charybdotoxin. Meanwhile, a biosensor binding assay showed a fast association rate and a slow dissociation rate of martentoxin binding on rat brain synaptosomes. The binding of martentoxin on rat brain synaptosomes could be inhibited regularly by charybdotoxin, and gradually by toosendanin in a concentration-dependent manner, but not by either apamin or P03 from Buthus martensi. The results thus indicate that martentoxin is a new member in the family of K+-channel-blocking ligands.


Subject(s)
Peptides/chemistry , Peptides/genetics , Potassium Channel Blockers/chemistry , Scorpion Venoms/chemistry , Scorpion Venoms/genetics , Amino Acid Sequence , Animals , Base Sequence , Binding, Competitive/drug effects , Chromaffin Cells/drug effects , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , Dose-Response Relationship, Drug , Electrophysiology , Genomic Library , Molecular Sequence Data , Patch-Clamp Techniques , Peptides/pharmacology , Phylogeny , Potassium Channel Blockers/isolation & purification , Potassium Channel Blockers/pharmacokinetics , Potassium Channels, Calcium-Activated/drug effects , Rats , Scorpion Venoms/pharmacology , Synaptosomes/chemistry , Synaptosomes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL